Amifostine: Is there evidence of tumor protection?KOUKOURAKIS, Michael I.Seminars in oncology. 2003, Vol 30, Num 6, pp 18-30, issn 0093-7754, 13 p., SUP18Conference Paper

Randomized trials of amifostine and radiotherapy : Effect on survival?BOURHIS, J; THEPHAMONGKHOL, K; PIGNON, J. P et al.Seminars in oncology. 2004, Vol 31, Num 6, pp 62-66, issn 0093-7754, 5 p., SUP18Conference Paper

Effect of Amifostine on Survival Among Patients Treated With Radiotherapy: A Meta-Analysis of Individual Patient DataBOURHIS, Jean; BLANCHARD, Pierre; PIGNON, Jean Pierre et al.Journal of clinical oncology. 2011, Vol 29, Num 18, pp 2590-2597, issn 0732-183X, 8 p.Article

Ongoing prospective multicenter safety study of the cytoprotectant amifostine given subcutaneously: Overview of trial designSAMUELS, Michael A; CHICO, Isagani M; HIRSCH, Robert L et al.Seminars in oncology. 2003, Vol 30, Num 6, pp 94-95, issn 0093-7754, 2 p., SUP18Conference Paper

Amifostine in the treatment of patients with myelodysplastic syndromeLARSEN, S. R; MANOHARAN, A.Australian and New Zealand journal of medicine. 1999, Vol 29, Num 5, pp 753-754, issn 0004-8291Article

Amifostine protects against chemotherapy-induced neurotoxicity: An In vitro investigationVERSTAPPEN, Carla C. P; POSTMA, Tjeerd J; GELDOF, Albert A et al.Anticancer research. 2004, Vol 24, Num 4, pp 2337-2341, issn 0250-7005, 5 p.Article

Radioprotection of Osteoblasts by a Fractionated Dose Regimen and AmifostineWONG, Alex K; MEI, Lily; SOARES, Marc A et al.Plastic and reconstructive surgery (1963). 2009, Vol 123, Num 2S, issn 0032-1052, 104S-113S, SUPConference Paper

Efficacy and tolerability of amifostine in elderly cancer patients. CommentaryBARUTCA, Sabri; MEYDAN, Nezih; AKAR, Harun et al.Current therapeutic research. 2004, Vol 65, Num 1, issn 0011-393X, 112,113-124 [13 p.]Article

Feasibility of amifostine administration in conjunction with high-dose rate brachytherapyDZIUK, Timothy; SENZER, Neil.Seminars in oncology. 2003, Vol 30, Num 6, pp 49-57, issn 0093-7754, 9 p., SUP18Conference Paper

Use of amifostine, a novel cytoprotective, in α-amanitin poisoningWILLS, Brandon K; HALLER, Nairmeen Awad; PETER, David et al.Journal of toxicology. Clinical toxicology. 2005, Vol 43, Num 4, pp 261-267, issn 0731-3810, 7 p.Article

A risk-benefit assessment of amifostine in cytoprotectionMABRO, M; FAIVRE, S; RAYMOND, E et al.Drug safety. 1999, Vol 21, Num 5, pp 367-387, issn 0114-5916Article

Myeloprotective effects of different amifostine regimens in rabbits undergoing high-dose treatment with ¹⁸⁶rhenium-(tin)1,1-hydroxyethylidene diphosphonate (¹⁸⁶Re-HEDP)BRENNER, Winfried; KAMPEN, Willm Uwe; BRÜMMER, Corinna et al.Cancer biotherapy & radiopharmaceuticals. 2003, Vol 18, Num 6, pp 887-893, issn 1084-9785, 7 p.Article

The second international cytoprotection investigators' congressCURRAN, Walter J.Seminars in oncology. 2002, Vol 29, Num 6, issn 0093-7754, 86 p., SUP19Conference Proceedings

Alteration of radiation-induced hematotoxicity by amifostineMOMM, Felix; BECHTOLD, Christine; RUDAT, Volker et al.International journal of radiation oncology, biology, physics. 2001, Vol 51, Num 4, pp 947-951, issn 0360-3016Article

Individualization of the subcutaneous amifostine dose during hypofractionated / accelerated radiotherapyKOUKOURAKIS, Michael I; ABATZOGLOU, Ioannis; SIVRIDIS, Leonidas et al.Anticancer research. 2006, Vol 26, Num 3B, pp 2437-2443, issn 0250-7005, 7 p.Article

A comparison of the action of amifostine and melatonin on DNA- damaging effects and apoptosis induced by idarubicin in normal and cancer cellsMAJSTEREK, Ireneusz; GLOC, Ewa; BLASIAK, Janusz et al.Journal of pineal research. 2005, Vol 38, Num 4, pp 254-263, issn 0742-3098, 10 p.Article

Prevention of radiation-induced central nervous system toxicity: A role for amifostine?NIEDER, Carsten; ANDRATSCHKE, Nicolaus H; WIEDENMANN, Nicole et al.Anticancer research. 2004, Vol 24, Num 6, pp 3803-3809, issn 0250-7005, 7 p.Article

Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancerTHORSTAD, Wade L; CLIFFORD CHAO, K. S; HAUGHEY, Bruce et al.Seminars in oncology. 2004, Vol 31, Num 6, pp 8-12, issn 0093-7754, 5 p., SUP18Conference Paper

Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostineCLIFFORD CHAO, K. S; OZYIGIT, Gokhan; THORSDAD, Wade L et al.Seminars in oncology. 2003, Vol 30, Num 6, pp 101-108, issn 0093-7754, 8 p., SUP18Conference Paper

Microvessel density and endothelial cell proliferation after amifostine (Ethyol®) administration in vivoPLASSWILM, L; HANJALIC, A; HOEPER, J et al.Anticancer research. 1999, Vol 19, Num 5B, pp 4241-4245, issn 0250-7005Article

Zebrafish as a biosensor? Effects of ionizing radiation and amifostine on embryonic viability and developmentGEIGER, Geoffrey A; PARKER, Sharon E; BEOTHY, Andrew P et al.Cancer research (Baltimore). 2006, Vol 66, Num 16, pp 8172-8181, issn 0008-5472, 10 p.Article

Réactions cutanées graves et amifostine = Severe cutaneous reactions with amifostineLa Revue Prescrire. 2003, Vol 23, Num 239, issn 0247-7750, p. 347Article

Amifostine : a radioprotector in locally advanced head and neck tumorsWAGNER, W; PROTT, F.-J; SCHÖNEKÄS, K. G et al.Oncology reports. 1998, Vol 5, Num 5, pp 1255-1257, issn 1021-335XArticle

Effects of amifostine on glycerol-pretreated rabbit kidneysBARUN, Süreyya; ERTOY, Dilek; DILEKÖZ, Ergin et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 97, Num 3, pp 168-173, issn 1742-7835, 6 p.Article

In vivo study to evaluate the protective effects of amifostine on radiation- induced damage of testis tissueANDRIEU, Meltem Nalca; KURTMAN, Cengiz; HICSONMEZ, Ayse et al.Oncology. 2005, Vol 69, Num 1, pp 44-51, issn 0030-2414, 8 p.Article